A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
Clinical trial NCT05826990 · RECRUITING
Trial details
- NCT number
- NCT05826990
- Sponsor
- Orchid Pharma Europe GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2029-05-21
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.